AR223656A1 - Procedimiento para obtener derivados de 2-feniliminoimidazolidina - Google Patents

Procedimiento para obtener derivados de 2-feniliminoimidazolidina

Info

Publication number
AR223656A1
AR223656A1 AR274367A AR27436778A AR223656A1 AR 223656 A1 AR223656 A1 AR 223656A1 AR 274367 A AR274367 A AR 274367A AR 27436778 A AR27436778 A AR 27436778A AR 223656 A1 AR223656 A1 AR 223656A1
Authority
AR
Argentina
Prior art keywords
phenyliminoimidazolidine
derivatives
procedure
obtaining
phenyliminoimidazolidine derivatives
Prior art date
Application number
AR274367A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR223656A1 publication Critical patent/AR223656A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
AR274367A 1977-11-07 1978-11-07 Procedimiento para obtener derivados de 2-feniliminoimidazolidina AR223656A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78467 1977-11-07
CH966878 1978-09-15

Publications (1)

Publication Number Publication Date
AR223656A1 true AR223656A1 (es) 1981-09-15

Family

ID=25705131

Family Applications (1)

Application Number Title Priority Date Filing Date
AR274367A AR223656A1 (es) 1977-11-07 1978-11-07 Procedimiento para obtener derivados de 2-feniliminoimidazolidina

Country Status (30)

Country Link
US (3) US4244957A (xx)
EP (1) EP0002010B1 (xx)
JP (1) JPS5473779A (xx)
AR (1) AR223656A1 (xx)
AT (1) AT371112B (xx)
AU (1) AU4132478A (xx)
BR (1) BR7807317A (xx)
CA (1) CA1106847A (xx)
CS (1) CS212309B2 (xx)
DD (1) DD139847A5 (xx)
DE (2) DE2847766A1 (xx)
DK (1) DK494978A (xx)
EG (1) EG13665A (xx)
ES (3) ES480111A1 (xx)
FI (1) FI783393A (xx)
FR (1) FR2407919A1 (xx)
GB (2) GB2086379B (xx)
IL (1) IL55832A0 (xx)
IT (1) IT1160046B (xx)
MC (1) MC1223A1 (xx)
MT (1) MTP837B (xx)
NL (1) NL7811070A (xx)
NO (1) NO783719L (xx)
NZ (1) NZ188798A (xx)
OA (1) OA06084A (xx)
PL (1) PL210759A1 (xx)
PT (1) PT68752A (xx)
RO (1) RO76151A (xx)
SE (1) SE7811455L (xx)
SU (2) SU831073A3 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287201A (en) * 1980-03-03 1981-09-01 Merck & Co., Inc. Anovulatory method and chicken feed compositions
CA1175434A (en) * 1980-09-10 1984-10-02 Hoffmann-La Roche Limited ¬(2-phenylamino-1-imidazolidinyloxy)methyl| pyridine 1-oxide derivatives
DE3642453A1 (de) * 1986-12-12 1988-06-23 Bayer Ag Neue, fluor enthaltende 5-trihalogenmethyl-isoxazole und ein verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
JP2004502757A (ja) * 2000-07-07 2004-01-29 メディキュア　インターナショナル　インコーポレイテッド ピリドキシンおよびピリドキサール類縁体：心血管系治療薬
GB2374251A (en) * 2001-04-04 2002-10-09 Secr Defence Base station transmitter
US20030139606A1 (en) * 2001-11-09 2003-07-24 Ray Anup Kumar Process for preparing 5-methylisoxazole-4-carboxylic- (4'-trifluoromethyl)-anilide
EP1333028A1 (en) * 2002-01-31 2003-08-06 Boehringer Ingelheim Pharma GmbH & Co.KG 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
US6703409B2 (en) 2002-01-31 2004-03-09 Boehringer Ingelheim Pharma Gmbh & Co Kg 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug
BRPI0917819B8 (pt) 2008-08-22 2021-05-25 Baxalta GmbH compostos derivados poliméricos de benzil carbonato, conjugado de droga, formulação farmacêutica, e, uso de um conjugado

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670274U (de) 1953-07-30 1954-01-14 Leo Schirk Stahlblechschalttafel.
DE1815788U (de) 1959-12-12 1960-07-28 Walther Loeffler Ventil fuer spuelbecken, waschbecken, bidets, wannen.
US3236857A (en) 1961-10-09 1966-02-22 Boehringer Sohn Ingelheim 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products
NL123037C (xx) 1963-10-04
DE1545628A1 (de) * 1965-10-01 1970-06-25 Boehringer Sohn Ingelheim Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2)
DE1670274A1 (de) * 1966-10-31 1970-07-16 Boehringer Sohn Ingelheim Neues Verfahren zur Herstellung von 2-Arylamino-1,3-diazacycloalkenen-(2)
DE1670230A1 (de) 1967-05-26 1971-01-21 Boehringer Sohn Ingelheim Neues Verfahren zur Herstellung von in 2-Stellung substituierten 1,3-Diazacycloalkenen(2)
ES352379A1 (es) 1967-05-26 1969-08-01 Boehringer Sohn Ingelheim Procedimiento para la preparacion de 1,3-diazaciclopenteno-(2) sustituido en posicion 2.
US3454301A (en) * 1967-09-29 1969-07-08 John W Lehmann Glare-inhibiting device
GB1246312A (en) * 1968-01-10 1971-09-15 Syntex Energy Res Inc 4,5-substituted n-oxy and hydroxy hydroimidazoles
DE1770872A1 (de) 1968-08-26 1972-01-13 Dresden Arzneimittel Verfahren zur Herstellung von Imidazolin-2-Derivaten
BE721781A (xx) 1968-10-03 1969-04-03
BE759048A (fr) * 1969-11-17 1971-05-17 Boehringer Sohn Ingelheim Nouvelles n-aminoalcoyl-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE2016290A1 (de) * 1970-04-06 1971-11-04 C H Boehrmger Sohn, 6507 Ingel heim Substituierte N Hydroxylakyl 2 arylamine) imidazoline (2) und Verfahren zu deren Herstellung
US3740412A (en) * 1970-04-08 1973-06-19 Synvar Ass Imidazoline-3-oxide-1-oxyl derivatives
DE2038107A1 (de) * 1970-07-31 1972-02-10 Henkel & Cie Gmbh Fluessige,gegebenenfalls als Wasch- oder Reinigungsmittel brauchbare stabilisierte Enzympraeparate
US3799942A (en) * 1971-04-12 1974-03-26 Syva Corp 4,5-substituted n-oxy and hydroxy hydroimidazoles
BE787477A (fr) * 1971-08-12 1973-02-12 Bayer Ag 1-phenyl-2-imino-imidazolidines, leur procede de preparation etleur application comme repulsifs a l'egard des oiseaux
DE2457979A1 (de) 1974-12-07 1976-06-16 Beiersdorf Ag 2-n-aryl-hydroxyamino-imidazoline-(2) und verfahren zu deren herstellung
DE2523103C3 (de) * 1975-05-24 1979-11-29 C.H. Boehringer Sohn, 6507 Ingelheim Substituierte 2-[N-Progargyl-N-(2-chlorphenyl)amino] -imidazoline-^), deren Säureadditionssalze, Verfahren zu ihrer Herstellung und deren Verwendung
AT339897B (de) * 1975-09-25 1977-11-10 Chemie Linz Ag Verfahren zur herstellung des neuen 1-benzoyl-2- (2',6'-dichlorphenylamino) -2-imidazolins und von dessen salzen
DE2626128A1 (de) * 1976-06-11 1977-12-22 Beiersdorf Ag N-substituierte benzimidazolin-2-one und verfahren zu deren herstellung
DE2709720A1 (de) * 1977-03-05 1978-09-07 Beiersdorf Ag N-substituierte 2-arylamino-imidazoline-(2), verfahren zu deren herstellung und neue hydroxylamine als zwischenprodukte
US4131679A (en) * 1977-07-26 1978-12-26 Sandoz, Inc. Substituted 4-hydroxy pyridones
DE2811847A1 (de) * 1978-03-17 1979-09-20 Lentia Gmbh Neue arylaminoimidazolinderivate, deren herstellung und verwendung als arzneimittel

Also Published As

Publication number Publication date
GB2086379A (en) 1982-05-12
IT7829486A0 (it) 1978-11-06
AU4132478A (en) 1979-05-17
ES480111A1 (es) 1980-04-01
GB2008579A (en) 1979-06-06
GB2086379B (en) 1982-11-10
OA06084A (fr) 1981-06-30
DE2861952D1 (en) 1982-09-02
EP0002010A1 (de) 1979-05-30
US4511720A (en) 1985-04-16
EP0002010B1 (de) 1982-07-14
ES480113A1 (es) 1980-04-01
NO783719L (no) 1979-05-08
JPS5473779A (en) 1979-06-13
EG13665A (en) 1982-03-31
MC1223A1 (fr) 1979-07-20
SU831073A3 (ru) 1981-05-15
MTP837B (en) 1979-10-22
CS212309B2 (en) 1982-03-26
BR7807317A (pt) 1979-07-24
FR2407919A1 (fr) 1979-06-01
IT1160046B (it) 1987-03-04
ATA791378A (de) 1982-10-15
GB2008579B (en) 1982-11-03
ES480112A1 (es) 1980-04-01
NZ188798A (en) 1981-04-24
AT371112B (de) 1983-06-10
SE7811455L (sv) 1979-07-02
IL55832A0 (en) 1978-12-17
PT68752A (en) 1978-12-01
DE2847766A1 (de) 1979-05-10
US4244957A (en) 1981-01-13
CA1106847A (en) 1981-08-11
FI783393A (fi) 1979-05-08
US4355033A (en) 1982-10-19
RO76151A (ro) 1981-08-30
DK494978A (da) 1979-05-08
PL210759A1 (xx) 1980-03-10
DD139847A5 (de) 1980-01-23
NL7811070A (nl) 1979-05-09
SU910119A3 (ru) 1982-02-28

Similar Documents

Publication Publication Date Title
MX147446A (es) Procedimiento mejorado para la etilacion de benceno
MX5950E (es) Procedimiento para la preparacion de derivados de la pirrolidin-2-ona
MX5527E (es) Procedimiento para la preparacion de derivados de carboestirilo
MX4988E (es) Procedimiento para la preparacion de derivados pirrolidinicos
MX5535E (es) Procedimiento para preparar 2-alfa-ciano-3-oxo-esteroides
MX5352E (es) Procedimiento mejorado para la obtencion de alquenilsuccinimidas
MX148160A (es) Procedimiento mejorado para la obtencion de alcoxisilanos
AR226694A1 (es) Procedimiento para obtener nuevos derivados de antraciclina
MX148906A (es) Procedimiento para la obtencion de dihidroxipoliuretanos
MX5479E (es) Procedimiento para la preparacion de derivados de 1-oxadetiacefalosporinas
MX151851A (es) Procedimiento mejorado para preparar derivados de triacina
ES488717A0 (es) Procedimiento para la obtencion de derivados de pirazol
AR223656A1 (es) Procedimiento para obtener derivados de 2-feniliminoimidazolidina
AR220145A1 (es) Procedimiento de preparacion de derivados de la sisomicina
AR221845A1 (es) Procedimiento para la obtencion de nuevas n1-glucofuranosid-6-i1-n3-ureas
MX5160E (es) Procedimiento mejorado para preparar derivados de aminoalcoholes
AR223465A1 (es) Procedimiento para obtener derivados de 5-bencil-2,4-diamino-pirimidinas
AR218933A1 (es) Procedimiento para obtener derivados de oxazolidona-2
MX5434E (es) Procedimiento para preparar cicloprofilcarboxilatos
MX4884E (es) Procedimiento para la preparacion de derivados de la tienopiridina
MX4478E (es) Procedimiento mejorado para la obtencion de derivados de acetanilidotiofosfato
ES490797A0 (es) Procedimiento para la obtencion de derivados de benzotiazol
MX5186E (es) Procedimiento para preparar eteres de benciloxima
ES495971A0 (es) Procedimiento para obtener derivados de tiazol
MX5208E (es) Procedimiento para preparar diclorovinilciclobutanonas